NEW YORK (GenomeWeb) – Genomics England has tapped LabKey Software to design and develop a solution based on the company's LabKey Server product to handle the integration and sharing of clinical and genomic data for the UK's 100,000 Genomes Project.
The 100,000 Genomes project aims to sequence whole genomes from UK patients with certain types of cancer or rare diseases as well as their families. LabKey's solution will facilitate aggregation, review, and integration of phenotype and genotype information across contributing labs, clinical sites and repositories, the partners said. It will also support clinicians and researchers' efforts to analyze this information to improve disease prediction and prevention, develop new diagnostics, and personalize treatments, they said.
Genomics England said it will issue a tender for the support and maintenance of LabKey's open source platform in the future.
Last month, Genomics England announced that it had contracted Congenica and Omicia to interpret genomic data from the first 8,000 patients participating in the UK project. It also said that it will continue working with Nanthealth and WuXiNextcode, and also with Lockheed Martin who are partnering with Cypher Genomics for the project.